Anti-malarial drug and TBI could have contributed to soldier's killing of civilians

07/24/2013 |

Army Staff Sgt. Robert Bales, who killed 16 Afghan civilians last year, had been given the anti-malarial drug mefloquine hydrochloride even though he had previously sustained a TBI, according to his attorney. An adverse event report from the FDA describes a scenario similar to that of Bales, although he is not mentioned by name. The drug, which military rules state should not be given in cases of TBI, can cause neurological side effects in 5% to 10% of users. Bales was also taking steroids, was under stress, may have been suffering from psychological trauma and could possibly have been drinking, according to witnesses.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health